Omeros (OMER) Gains from Investment Securities (2010 - 2026)
Omeros recorded quarterly Gains from Investment Securities of $183000.0 in Q1 2026, up 200.55% quarter-over-quarter from -$182000.0 in Q4 2025, and down 98.9% year-over-year from $16.6 million in Q1 2025.
Omeros' Gains from Investment Securities history runs 17 years deep, the most recent figure standing at $183000.0 for Q1 2026.
- In Q1 2026, Gains from Investment Securities fell 98.9% year-over-year to $183000.0; the TTM figure through Mar 2026 stood at -$1.3 million (down 107.6% YoY), while the FY2025 annual figure was $18.3 million, up 9.48% from the prior year.
- Gains from Investment Securities came in at $183000.0 for Q1 2026 at Omeros, up from -$182000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $40.7 million in Q4 2022 to a low of -$41.6 million in Q4 2023.
- A 5-year average of $2.9 million and a median of $427463.0 in 2025 frame the typical range for Gains from Investment Securities.
- Across the five-year window, Gains from Investment Securities soared 5860.76% in 2022 and slumped 1299.17% in 2024, its largest moves.
- Omeros' Gains from Investment Securities stood at $40.7 million in 2022, then tumbled by 202.27% to -$41.6 million in 2023, then jumped by 102.59% to $1.1 million in 2024, then plunged by 116.9% to -$182000.0 in 2025, then jumped by 200.55% to $183000.0 in 2026.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered $183000.0, -$182000.0, and $427463.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 183,000.00 |
| Mar 31, 2026 | 183,000.00 |
| Dec 31, 2025 | -182,000.00 |
| Dec 31, 2025 | -182,000.00 |
| Sep 30, 2025 | 427,463.00 |
| Sep 30, 2025 | 427,463.00 |
| Jun 30, 2025 | 3.30 Mn |
| Jun 30, 2025 | 3.30 Mn |
| Mar 31, 2025 | 16.60 Mn |
| Mar 31, 2025 | 16.60 Mn |
| Dec 31, 2024 | 1.08 Mn |
| Dec 31, 2024 | 1.08 Mn |
| Sep 30, 2024 | 3.28 Mn |
| Sep 30, 2024 | 3.28 Mn |
| Jun 30, 2024 | 327,751.00 |
| Jun 30, 2024 | 327,751.00 |
| Mar 31, 2024 | -2.34 Mn |
| Mar 31, 2024 | -2.34 Mn |
| Dec 31, 2023 | -41.59 Mn |
| Dec 31, 2023 | -41.59 Mn |
| Sep 30, 2023 | 1.44 Mn |
| Sep 30, 2023 | 1.44 Mn |
| Jun 30, 2023 | 10.18 Mn |
| Jun 30, 2023 | 10.18 Mn |
| Mar 31, 2023 | 195,052.00 |
| Mar 31, 2023 | 195,052.00 |
| Dec 31, 2022 | 40.67 Mn |
| Dec 31, 2022 | 40.67 Mn |
| Sep 30, 2022 | 14.67 Mn |
| Sep 30, 2022 | 14.67 Mn |
| Jun 30, 2022 | 367,273.00 |
| Jun 30, 2022 | 367,273.00 |
| Mar 31, 2022 | 253,000.00 |
| Mar 31, 2022 | 253,000.00 |
| Dec 31, 2021 | -706,000.00 |
| Dec 31, 2021 | -706,000.00 |
| Sep 30, 2021 | 348,258.00 |
| Sep 30, 2021 | 348,258.00 |
| Jun 30, 2021 | 11.32 Mn |
| Jun 30, 2021 | 11.32 Mn |
| Mar 31, 2021 | 11.56 Mn |
| Mar 31, 2021 | 11.56 Mn |
| Sep 30, 2020 | 12.10 Mn |
| Sep 30, 2020 | 12.10 Mn |
| Jun 30, 2020 | 142,158.00 |
| Jun 30, 2020 | 142,158.00 |
| Mar 31, 2020 | 22,000.00 |
| Mar 31, 2020 | 22,000.00 |
| Dec 31, 2019 | 554,000.00 |
| Dec 31, 2019 | 554,000.00 |
| Sep 30, 2019 | 260,831.00 |
| Sep 30, 2019 | 260,831.00 |
| Jun 30, 2019 | 135,869.00 |
| Jun 30, 2019 | 135,869.00 |
| Mar 31, 2019 | 254,000.00 |
| Mar 31, 2019 | 254,000.00 |
| Dec 31, 2018 | 372,000.00 |
| Dec 31, 2018 | 372,000.00 |
| Sep 30, 2018 | 221,000.00 |
| Sep 30, 2018 | 221,000.00 |
| Jun 30, 2018 | 358,000.00 |
| Jun 30, 2018 | 358,000.00 |
| Dec 31, 2017 | 509,000.00 |
| Dec 31, 2017 | 509,000.00 |
| Sep 30, 2017 | 469,000.00 |
| Sep 30, 2017 | 469,000.00 |
| Jun 30, 2017 | 93,000.00 |
| Jun 30, 2017 | 93,000.00 |
| Mar 31, 2017 | 70,000.00 |
| Mar 31, 2017 | 70,000.00 |
| Dec 31, 2016 | -388,000.00 |
| Dec 31, 2016 | -388,000.00 |
| Sep 30, 2016 | -370,000.00 |
| Sep 30, 2016 | -370,000.00 |
| Jun 30, 2016 | 758,000.00 |
| Jun 30, 2016 | 758,000.00 |
| Dec 31, 2015 | 137,000.00 |
| Dec 31, 2015 | 137,000.00 |
| Dec 31, 2014 | -663,000.00 |
| Dec 31, 2014 | -663,000.00 |
| Sep 30, 2014 | 411,000.00 |
| Sep 30, 2014 | 411,000.00 |
| Mar 31, 2014 | 452,000.00 |
| Mar 31, 2014 | 452,000.00 |
| Mar 31, 2013 | 41,000.00 |
| Mar 31, 2013 | 41,000.00 |
| Sep 30, 2012 | 58,169.00 |
| Sep 30, 2012 | 58,169.00 |
| Jun 30, 2012 | 4.13 Mn |
| Jun 30, 2012 | 4.13 Mn |
| Mar 31, 2012 | 511,000.00 |
| Mar 31, 2012 | 511,000.00 |
| Dec 31, 2011 | 3.01 Mn |
| Dec 31, 2011 | 3.01 Mn |
| Dec 31, 2010 | -168,000.00 |
| Dec 31, 2010 | -168,000.00 |